阿帕替尼治疗肺鳞癌1例

发布时间：2018-03-26 04:11

  本文选题：甲磺酸阿帕替尼　切入点：非小细胞肺癌　出处：《中国肿瘤临床》2017年02期

【摘要】：正患者女性,57岁,无吸烟史。因咳痰伴痰中带血1个月于2012年3月就诊陆军总医院,PET-CT检查提示:右肺癌,肺门、纵隔多发淋巴结转移,L2骨转移。免疫组织化学检测:肺来源可能性大。心包积液检测示:查见鳞癌(图1),EGFR基因突变阴性。诊断为:1)右肺鳞癌Ⅳ期(pT4N3M1),肺门、纵隔多发淋巴结转移癌,骨转移癌,心包积液。2)高血压Ⅲ级高危。患者拒绝放、化疗,服用靶向药物治疗。遂于2012年3月开始口服靶向药物
[Abstract]:The female patient, 57 years old, had no history of smoking. PET-CT examination at Army General Hospital in March 2012, due to expectoration and sputum with blood in one month, showed that: right lung cancer, hilar lung, Mediastinal multiple lymph node metastasis with L2 bone metastases. Immunohistochemical examination: lung origin is very likely. Pericardial effusion detection shows that squamous cell carcinoma (fig. 1) has negative EGFR gene mutation and is diagnosed as: right lung squamous cell carcinoma stage 鈪，

本文编号：1666274